Please assess the completion status of the following clinical trial:

Trial Title: Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Diagnosis of adenocarcinoma of the esophagus meeting the following criteria:~  * Stage II or III disease~ * Resectable disease~ * Previously untreated disease~* No stage I (mucosal only) or stage IV (metastatic) disease~PATIENT CHARACTERISTICS:~* WBC \> 3,000/mm\^3~* Absolute neutrophil count \> 1,500/mm\^3~* Platelet count \> 100,000/mm\^3~* Creatinine ≤ 2.0 mg/dL~* Bilirubin \< 2 times normal~* Not pregnant or nursing~* Negative pregnancy test~* Fertile patients must use effective contraception~* Must have central venous access~* No other malignancy within the past 5 years~* No concurrent medical or psychiatric problem that would preclude study treatment~* No contraindications to paclitaxel~PRIOR CONCURRENT THERAPY:~* No prior chemotherapy or radiotherapy to the esophagus~* No oral cryotherapy (e.g., ice chips) on day 1 of each course

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Study Arms:
- Neoadjuvant + Adjuvant Chemotherapy (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).